Cargando…

Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study

Aim To quantify and update the years of life lost (YLL), years lived with disability (YLD) and disability-adjusted life years (DALY) due to the adverse effects of medical treatment (AEMT) between 1990 and 2017. Subject and methods We analyzed the latest dataset from the Global Burden of Disease (GBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Moien AB, Soteriades, Elpidoforos S, King, Jeff, Govender, Romona, Hashim, Muhammad Jawad, Masood-Husain, Shamaila, Javaid, Syed Fahad, Debaib Mohammed Saeed Al Darei, Shaikha, Dahi Al Sheryani, Shamma, Nauman, Javaid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071843/
https://www.ncbi.nlm.nih.gov/pubmed/32195068
http://dx.doi.org/10.7759/cureus.7250
_version_ 1783506292712669184
author Khan, Moien AB
Soteriades, Elpidoforos S
King, Jeff
Govender, Romona
Hashim, Muhammad Jawad
Masood-Husain, Shamaila
Javaid, Syed Fahad
Debaib Mohammed Saeed Al Darei, Shaikha
Dahi Al Sheryani, Shamma
Nauman, Javaid
author_facet Khan, Moien AB
Soteriades, Elpidoforos S
King, Jeff
Govender, Romona
Hashim, Muhammad Jawad
Masood-Husain, Shamaila
Javaid, Syed Fahad
Debaib Mohammed Saeed Al Darei, Shaikha
Dahi Al Sheryani, Shamma
Nauman, Javaid
author_sort Khan, Moien AB
collection PubMed
description Aim To quantify and update the years of life lost (YLL), years lived with disability (YLD) and disability-adjusted life years (DALY) due to the adverse effects of medical treatment (AEMT) between 1990 and 2017. Subject and methods We analyzed the latest dataset from the Global Burden of Disease (GBD) 2017 study. We described the burden of AEMT based on the number of DALY. We additionally evaluated the global age and sex-specific DALY and compared the age-standardized rates of DALY across the World Health Organization (WHO) regions from 1990 to 2017. Results Worldwide, the total DALYs due to AEMT were 84.93 [95% uncertainty interval (UI), 62.52 to 102.21] in 1990 and 62.79 (52.09 to 75.45) in 2017 per 100,000 population. The global percentage of change in DALY showed a negative trend of −26.06 % (−41.52 to −10.59) across all WHO regions between 1990 and 2017. The YLD has increased during the period from 1997 to 2017 by 29.47% (17.87 to 41.06). In 2017, men were affected more than women with a DALY of 66.78 in comparison to 58.91 DALY in women. DALY rates per 100,000 were highest across all the WHO regions in the first years of life. The predicted DALY rates were 59.92 (57.52 to 62.32) in the year 2020, 50.36 (32.03 to 68.70) in 2030, and 40.8 (−1.33 to 82.93) in 2040. Conclusion Using the GBD 2017 study data, we found a decrease in the DALY rate due to AEMT between 1990 and 2017 with a varying range of DALY between different WHO regions. DALY also differed by age and sex. The forecasting analyses showed a decrease in DALY due to AEMTs with a significant drop in the European region when compared to the African and American regions. However, the increasing trend for YLD signifies an increasing burden of people living with poor health due to AEMT. Our study proposes to identify disability due to AEMT as a significant public health crisis and calls for policymakers to create a robust revised policy.
format Online
Article
Text
id pubmed-7071843
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70718432020-03-19 Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study Khan, Moien AB Soteriades, Elpidoforos S King, Jeff Govender, Romona Hashim, Muhammad Jawad Masood-Husain, Shamaila Javaid, Syed Fahad Debaib Mohammed Saeed Al Darei, Shaikha Dahi Al Sheryani, Shamma Nauman, Javaid Cureus Preventive Medicine Aim To quantify and update the years of life lost (YLL), years lived with disability (YLD) and disability-adjusted life years (DALY) due to the adverse effects of medical treatment (AEMT) between 1990 and 2017. Subject and methods We analyzed the latest dataset from the Global Burden of Disease (GBD) 2017 study. We described the burden of AEMT based on the number of DALY. We additionally evaluated the global age and sex-specific DALY and compared the age-standardized rates of DALY across the World Health Organization (WHO) regions from 1990 to 2017. Results Worldwide, the total DALYs due to AEMT were 84.93 [95% uncertainty interval (UI), 62.52 to 102.21] in 1990 and 62.79 (52.09 to 75.45) in 2017 per 100,000 population. The global percentage of change in DALY showed a negative trend of −26.06 % (−41.52 to −10.59) across all WHO regions between 1990 and 2017. The YLD has increased during the period from 1997 to 2017 by 29.47% (17.87 to 41.06). In 2017, men were affected more than women with a DALY of 66.78 in comparison to 58.91 DALY in women. DALY rates per 100,000 were highest across all the WHO regions in the first years of life. The predicted DALY rates were 59.92 (57.52 to 62.32) in the year 2020, 50.36 (32.03 to 68.70) in 2030, and 40.8 (−1.33 to 82.93) in 2040. Conclusion Using the GBD 2017 study data, we found a decrease in the DALY rate due to AEMT between 1990 and 2017 with a varying range of DALY between different WHO regions. DALY also differed by age and sex. The forecasting analyses showed a decrease in DALY due to AEMTs with a significant drop in the European region when compared to the African and American regions. However, the increasing trend for YLD signifies an increasing burden of people living with poor health due to AEMT. Our study proposes to identify disability due to AEMT as a significant public health crisis and calls for policymakers to create a robust revised policy. Cureus 2020-03-12 /pmc/articles/PMC7071843/ /pubmed/32195068 http://dx.doi.org/10.7759/cureus.7250 Text en Copyright © 2020, Khan et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Preventive Medicine
Khan, Moien AB
Soteriades, Elpidoforos S
King, Jeff
Govender, Romona
Hashim, Muhammad Jawad
Masood-Husain, Shamaila
Javaid, Syed Fahad
Debaib Mohammed Saeed Al Darei, Shaikha
Dahi Al Sheryani, Shamma
Nauman, Javaid
Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study
title Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study
title_full Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study
title_fullStr Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study
title_full_unstemmed Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study
title_short Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study
title_sort global trends and forecast of the burden of adverse effects of medical treatment: epidemiological analysis based on the global burden of disease study
topic Preventive Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071843/
https://www.ncbi.nlm.nih.gov/pubmed/32195068
http://dx.doi.org/10.7759/cureus.7250
work_keys_str_mv AT khanmoienab globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT soteriadeselpidofoross globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT kingjeff globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT govenderromona globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT hashimmuhammadjawad globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT masoodhusainshamaila globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT javaidsyedfahad globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT debaibmohammedsaeedaldareishaikha globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT dahialsheryanishamma globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy
AT naumanjavaid globaltrendsandforecastoftheburdenofadverseeffectsofmedicaltreatmentepidemiologicalanalysisbasedontheglobalburdenofdiseasestudy